Valeant Shares Drop After Sales Projections Fall Short
Valeant Pharmaceuticals International Inc.’s CEO said in late 2016 that he saw running the drugmaker as the “turnaround opportunity of a lifetime.” That’s not what Wednesday’s quarterly results suggest....